Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates

Stock News

Dec 02, 2025

Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. ("Sikon Biological"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. ("Zhengzhou Biaoyuan"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.

The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1164625297"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164625297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164625297?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164625297","market":"sg","top_or_hot":-1,"title":"Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates","media":"Stock News","content":"<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAutobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-02 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"","article_id":"1164625297","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164625297","pubTimestamp":1764668777,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","603658":"安图生物","BK1100":"医疗保健设备","09997":"康基医疗","09996":"沛嘉医疗-B","BK1222":"医疗保健用品","BK1574":"生物医药B类股","BK0046":"生物疫苗","BK0239":"医药制造","BK1583":"高瓴概念"},"translate_title":"奥特生物诊断（603658.SH）及子公司获得医疗器械注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"603658":1,"09997":1,"09996":1},"content_text":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.\nThe acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}